{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:15:10Z","timestamp":1791591310459,"version":"4.3.4"},"reference-count":43,"publisher":"American Society for Microbiology","issue":"4","license":[{"start":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T00:00:00Z","timestamp":1681776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T00:00:00Z","timestamp":1681776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/501100004281","name":"National Science Centre","doi-asserted-by":"publisher","award":["OPUS"],"award-info":[{"award-number":["OPUS"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"National Science Centre","doi-asserted-by":"publisher","award":["2019\/33\/B\/NZ6\/01283"],"award-info":[{"award-number":["2019\/33\/B\/NZ6\/01283"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006445","name":"University of Warsaw","doi-asserted-by":"crossref","award":["BOB-661-54\/2019"],"award-info":[{"award-number":["BOB-661-54\/2019"]}],"id":[{"id":"10.13039\/501100006445","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2023,4,18]]},"abstract":"<jats:p>\n            <jats:italic>Prototheca<\/jats:italic>\n            are unicellular, achlorophyllous, yeast-like microalgae that occur in a wide range of natural habitats. At least five species have been implicated as the causative agents of opportunistic infections of men.\n          <\/jats:p>","DOI":"10.1128\/aac.01627-22","type":"journal-article","created":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T14:09:22Z","timestamp":1679407762000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":14,"title":["Drug Susceptibility Profiling of\n            <i>Prototheca<\/i>\n            Species Isolated from Cases of Human Protothecosis"],"prefix":"10.1128","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6714-3354","authenticated-orcid":false,"given":"Angelika","family":"Proskurnicka","sequence":"first","affiliation":[{"name":"Department of Medical Microbiology, Institute of Microbiology, Faculty of Biology, University of Warsaw, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinga","family":"\u017bupnik","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Institute of Microbiology, Faculty of Biology, University of Warsaw, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7560-2100","authenticated-orcid":true,"given":"Zofia","family":"Baku\u0142a","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Institute of Microbiology, Faculty of Biology, University of Warsaw, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"Iskra","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Institute of Microbiology, Faculty of Biology, University of Warsaw, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"R\u00f6sler","sequence":"additional","affiliation":[{"name":"Institute for Animal Hygiene and Environmental Health, Freie Universit\u00e4t Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9553-5742","authenticated-orcid":false,"given":"Tomasz","family":"Jagielski","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Institute of Microbiology, Faculty of Biology, University of Warsaw, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mycmed.2007.08.003"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.myc.2019.02.003"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.algal.2019.101639"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/aem.01092-22"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.3109\/13693786.2012.677862"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00032-06"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1099\/ijsem.0.000911"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(64)90094-x"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myx162"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mjafi.2017.07.012"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.3109\/13693786.2010.511285"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks134"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1080\/13693780801993611"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00375"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.3168\/jds.2017-12597"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myz119"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkn107"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.1996.tb00526.x"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.10.1.75"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.35.11.2434"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2007.tb01313.x"},{"key":"e_1_3_3_23_2","unstructured":"U.S. Food and Drug Administration. List of FDA-approved drugs. Available online: https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=BasicSearch.process (Accessed on 11 January 2023)."},{"key":"e_1_3_3_24_2","unstructured":"U.S. Food and Drug Administration. FDA drug safety communication: FDA limits usage of Nizoral (ketoconazole) oral tablets due to potentially fatal liver injury and risk of drug interactions and adrenal gland problems. Available online: https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-limits-usage-nizoral-ketoconazole-oral-tablets-due-potentially (Accessed on 11 January 2023)."},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.2147\/CE.S49629"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1080\/13693780802541518"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.3168\/jds.S0022-0302(06)72465-1"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.43.5.2520-2522.2005"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.riam.2009.06.003"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.5.1493-1499.2001"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02056-12"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/myc.12870"},{"key":"e_1_3_3_33_2","unstructured":"U.S. Food and Drug Administration. Drug approval package for Jublia topical solution 10%. Available online: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2014\/203567_jublia_toc.cfm (Accessed on 24 October 2022)."},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-013-0152-x"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.7547\/8750-7315-104.6.568"},{"key":"e_1_3_3_36_2","first-page":"815","article-title":"The efficacy and safety of efinaconazole 10% solution for treatment of mild to moderate onychomycosis: a pooled analysis of two phase 3 randomized trials","volume":"13","author":"Gupta AK","year":"2014","unstructured":"Gupta AK, Elewski BE, Sugarman JL, Ieda C, Kawabata H, Kang R, Pillai R, Olin JT, Watanabe S. 2014. The efficacy and safety of efinaconazole 10% solution for treatment of mild to moderate onychomycosis: a pooled analysis of two phase 3 randomized trials. J Drugs Dermatol 13:815\u2013820.","journal-title":"J Drugs Dermatol"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00584-18"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/database\/baab073"},{"key":"e_1_3_3_39_2","volume-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts","author":"CLSI","year":"2008","unstructured":"CLSI. 2008. Reference method for broth dilution antifungal susceptibility testing of yeasts; Approved Standard-3rd ed CLSI document M27-A3.","edition":"3"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-021-07491-8"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.00443"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.3168\/jds.2020-18171"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/lam.13696"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.2217\/nnm-2017-0370"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.01627-22","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.01627-22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T13:07:27Z","timestamp":1681823247000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/aac.01627-22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,18]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4,18]]}},"alternative-id":["10.1128\/aac.01627-22"],"URL":"https:\/\/doi.org\/10.1128\/aac.01627-22","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,18]]},"assertion":[{"value":"2022-12-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-31","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01627-22"}}